Fibrin clots resulting from the action of coagulase thrombin were subjected to Polyacrylamide gel electrophoresis in the presence of hirudin or of heparin to exclude the action of biothrombin.
Alpha, beta, and gamma polypeptide chains were resolved not differing from those induced by the action of thrombin on fibrinogen.
No evidence was found of any further degradation of any of the polypeptide chains.
Although coagulase thrombin fails to activate factor XIII at calcium ion concentrations effective for the cross-linking of fibrin by thrombin, higher concentrations of calcium lead to the activation of factor XIII by coagulase thrombin, resulting in gamma dimer formation.
The data support the evidence that coagulase thrombin, like biothrombin, acts as a limited proteolytic agent on fibrinogen.
References
1
Brummel M. C,
Montgomery R.
Acrylamide gel electrophoresis of the S-sulfo derivatives of fibrinogen. Analytical Biochemistry 1970; 33: 28
2
Cohn E. J,
Strong L. E,
Hughes Jr. W. L,
Mulford D. J,
Ashworth J. N,
Melin M,
Taylor H. L.
Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. Journal of the American Chemical Society 1946; 68: 459
3
Drummond M. C,
Tager M.
Enzymatic activities associated with clotting of fibrinogen by staphylocoagulase and coagulase reacting factor and their inhibition by diisopropylfluorophosphate. Journal of Bacteriology 1962; 83: 975
4
Drummond M. C,
Tager M.
Fibrinogen clotting and fibrino-peptide formation by staphylocoagulase and the coagulase-reacting factor. Journal of Bacteriology 1963; 85: 628
5
Haughton G,
Duthie E. S.
The activation of staphylococcal free coagulase by plasma constituents and the hydrolysis of N-toluene-p-sufonyl-L-arginine methyl ester (TAMe) by activated coagulase. The Biochemical Journal 1959; 71: 348
6
Heene D. L.
Quantitative estimation of fibrin stabilizing factor, alterations of its activity by fibrinolysis. Thrombosis et Diathesis Haemorrhagica 1968; 10: 600
8
Kopec M,
Wegrzynowicz Z,
Budzynski A. Z,
JeljaszewiCz J,
Latallo Z. S,
Lipinski B,
Kowalski E.
Formation and properties of fibrin clots resulting from staphylocoagulase action. Thrombosis et Diathesis Hemorrhagica 1967; 18: 475
9
Kopec M,
Latallo Z. S,
Stahl M,
Wegrzynowicz Z.
The effect of proteolytic enzymes on fibrin stabilizing factor. Biochimica et Biophysica Acta 1969; 181: 437
11
McKee P. A,
Mattock P,
Hill R. L.
Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. Proceedings of the National Academy of Sciences 1970; 66: 738
14
Schwartz M. L,
Pizzo S. V,
Hill R. L,
McKee P. A.
The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. Journal of Clinical Investigation 1971; 50: 1506
19
Tager M.
1948; a Studies on the coagulase reacting factor, I. The reaction of staphy-locoagulase with the components of human plasma. Yale Journal of Biology and Medicine 20: 369
21
Tager M.
Studies on the nature and the purification of the coagulase-reacting factor and its relation to prothrombin. Journal of Experimental Medicine 1956; 104: 675
24
Weber K,
Osborn M.
The reliability of molecular weight determinations by dodecyl sulfate Polyacrylamide gel electrophoresis. Journal of Biological Chemistry 1969; 244: 4406
